<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Mutations in protein-O-<z:chebi fb="0" ids="37684">mannose</z:chebi>-beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) have been found in muscle-eye-<z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e>, a <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> with structural eye and brain defects and <z:hpo ids='HP_0010864'>severe mental retardation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To investigate whether mutations in POMGnT1 could be responsible for milder allelic variants of <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Screening for mutations in POMGnT1 </plain></SENT>
<SENT sid="3" pm="."><plain>SETTING: Tertiary neuromuscular unit </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENT: A patient with <z:hpo ids='HP_0006785'>limb-girdle muscular dystrophy</z:hpo> phenotype, with <z:hpo ids='HP_0003674'>onset</z:hpo> at 12 years of age, <z:hpo ids='HP_0011003'>severe myopia</z:hpo>, <z:mpath ids='MPATH_458'>normal</z:mpath> intellect, and decreased alpha-dystroglycan immunolabeling in skeletal muscle </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A homozygous POMGnT1 missense mutation (c.1666G&gt;A, p.Asp556Asn) was identified </plain></SENT>
<SENT sid="6" pm="."><plain>Enzyme studies of the patient's fibroblasts showed an altered kinetic profile, less marked than in patients with muscle-eye-<z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e> and in keeping with the relatively mild phenotype in our patient </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our findings widen the spectrum of disorders known to result from mutations in POMGnT1 to include <z:hpo ids='HP_0006785'>limb-girdle muscular dystrophy</z:hpo> with no <z:hpo ids='HP_0001249'>mental retardation</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>We propose that this condition be known as LGMD2M </plain></SENT>
<SENT sid="9" pm="."><plain>The enzyme assay used to diagnose muscle-eye-<z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e> may not detect subtle abnormalities of POMGnT1 function, and additional kinetic studies must be carried out in such cases </plain></SENT>
</text></document>